Compare LSTA & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSTA | FTHM |
|---|---|---|
| Founded | 1980 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 11.4M |
| IPO Year | 2000 | 2020 |
| Metric | LSTA | FTHM |
|---|---|---|
| Price | $1.13 | $0.08 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 115.7K | ★ 348.3K |
| Earning Date | 11-27-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.42 | ★ 32.71 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,283,868.00 | N/A |
| Revenue This Year | N/A | $9.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 56.90 | N/A |
| 52 Week Low | $0.96 | $0.08 |
| 52 Week High | $5.07 | $1.52 |
| Indicator | LSTA | FTHM |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 18.61 |
| Support Level | $0.98 | N/A |
| Resistance Level | $1.28 | $0.20 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 32.58 | 4.53 |
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, and Software as a Service (SaaS) offerings to brokerages and agents by leveraging intelliAgent , proprietary cloud-based software. The Company's three operating and reportable segments: Real Estate Brokerage, Mortgage, and Title. The majority of revenue is from Real Estate Brokerage, which provides real estate brokerage services.